Loading…

Thrombotic complications without evidence of hemolysis in paroxysmal nocturnal hemoglobinuria: is eculizumab indicated?

Saved in:

Bibliographic Details
Published in:	Annals of hematology 2012-12, Vol.91 (12), p.1969-1970
Main Authors:	Bellido, M., van der Velden, V. H. J., Leebeek, F. W. G., te Boekhorst, P. A. W.
Format:	Article
Language:	English
Subjects:	Adult Anemia, Aplastic - etiology Anemia, Aplastic - therapy Anticoagulants - adverse effects Anticoagulants - therapeutic use Brain Ischemia - physiopathology Cerebral Hemorrhage - chemically induced Cerebral Hemorrhage - etiology Cerebral Hemorrhage - physiopathology Fatal Outcome Hematology Hemoglobinuria, Paroxysmal - complications Hemoglobinuria, Paroxysmal - drug therapy Hemoglobinuria, Paroxysmal - physiopathology Hepatitis, Autoimmune - complications Humans Immunosuppressive Agents - therapeutic use Letter to the Editor Male Medicine Medicine & Public Health Mesenteric Vascular Occlusion - complications Mesenteric Vascular Occlusion - drug therapy Nadroparin - adverse effects Nadroparin - therapeutic use Occipital Lobe Oncology Paresis - etiology Parietal Lobe Transfusion Reaction Venous Thrombosis - complications Venous Thrombosis - drug therapy
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!